2025 Legislative Update
Most states adjourned their 2025 regular legislative sessions mid-year. A handful of states remain in regular session and a smattering of states have returned or are expected to convene special sessions to address budget and other issues. While the pace of legislation activity has slowed, TDC Group’s Government Relations team continues to advocate on pending legislation, prepare with coalitions for the 2026 legislative sessions, and engage in key judicial actions warranting an amicus curiae voice.
Search
February 21, 2024, Journal of the American College of Cardiology
Professional Liability: The Problem That Will Not Go Away
The frequency of malpractice claims in the United States has trended downward in the last 10 to 15 years, however, there is an upward trend in the “severity” of claims, driven in large part by “nuclear” jury verdicts. Cardiologists and other clinicians should always be aware that a lack of communication is a common causal factor in malpractice suits. Richard E. Anderson, MD, FACP, Chairman and CEO, The Doctors Company and TDC Group, investigates claim amounts and severity alongside three prominent physicians.
Corporate Influence on Primary Care
Corporate entities have always been involved in healthcare, but now mega corporations—from outside the medical space—are entering the field. The involvement of these large non-legacy corporate entities in healthcare is growing and is challenging—and while this trend brings some benefits, it will also impact how all clinicians provide healthcare.
Exclusively Endorsed by ASPS
The American Society of Plastic Surgeons exclusively endorses The Doctors Company. ASPS members receive unique benefits, including exclusive program discounts and credits.
December 01, 2024, South Florida Hospital News and Healthcare Report
The Rising Threat of Nuclear Verdicts in Medical Malpractice: A Call for Tort Reform
Dr. Patricia Ares-Romero discusses the increasing trend of "nuclear verdicts"—jury awards exceeding $10 million—in medical malpractice cases. She highlights insights from Bob White, President of The Doctors Company and TDC Group, noting that from 2013 to 2023, these verdicts surged by 67%, with the average award among the top 50 malpractice verdicts rising from $32 million in 2022 to $48 million in 2023.
December 15, 2023, Inside Medical Liability
MPL Cases: What Are the Primary Drivers of High-Indemnity Medical Malpractice Claims?
Jacqueline Ross, RN, PhD, Coding Director, and Kathrine Soulsby, RN, BSN, Senior Patient Safety Analyst, The Doctors Company, part of TDC Group, investigate high-dollar medical malpractice litigation and explain how reducing diagnostic errors is paramount to enhancing patient safety and mitigating loss costs.
Mar 07, 2023
Spotlight on Foundation Grants: Enhanced Diagnostic Reasoning
A grant to the University of Michigan supports a project to boost trainees’ skills by employing a unique combination of ambient and artificial intelligence.
From
The Doctor’s Advocate
Community Oncology Alliance Partnership
The Community Oncology Alliance (COA) has chosen The Doctors Company, part of TDC Group, as the exclusively endorsed medical malpractice insurer for its members.
Video Aug 29, 2025
What Is Hospital at Home?
Michael J. Maniaci, MD, Director of Enterprise Virtual Care, Mayo Clinic, presents at the 2025 TDC Group Executive Advisory Board Meeting, explaining how hospital at home programs provide inpatient care to patients in the comfort of their own homes as an alternative to traditional brick-and-mortar hospital care.
Overview of Obesity-Related Malpractice Claims
The Doctors Company continues to see an increase in lawsuits involving patients with obesity.
